NCT05892809 is a NA clinical trial of use an incubator cover in Neonatal Disease, sponsored by Maltepe University.

Who is sponsoring NCT05892809?

NCT05892809 is sponsored by Maltepe University.

What drugs are being tested in NCT05892809?

Interventions in NCT05892809: use an incubator cover.

What condition does NCT05892809 study?

NCT05892809 studies Neonatal Disease, Nursing Caries.

Is NCT05892809 still recruiting?

NCT05892809 is currently completed. Last updated 7 June 2023.

Last reviewed 2023-06-07 · How we verify

NCT05892809

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of an Incubator Cover on Term and Preterm Neonates' Vital Signs

Completed NA Last updated 7 June 2023

What this trial tests

NA trial testing use an incubator cover in Neonatal Disease in 91 participants. Completed in 1 January 2019.

Timeline

1 March 2018

Primary endpoint
1 June 2018

1 January 2019

Quick facts

Lead sponsor	Maltepe University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	91
Start date	1 March 2018
Primary completion	1 June 2018
Estimated completion	1 January 2019
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

use an incubator cover

Conditions studied

Neonatal Disease — all drugs for Neonatal Disease →
Nursing Caries — all drugs for Nursing Caries →

Sponsor

Maltepe University

Who can join

Adults 24 Weeks to 42 Weeks, any sex, with Neonatal Disease or Nursing Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effect of an incubator cover on the vital signs of term and preterm neonates hospitalized in a neonatal intensive care unit. Methods: 91 neonates presenting to a neonatal intensive care unit who met the inclusion criteria were included in the study. Vital signs of neonates were measured with and without incubator cover. Measurements were performed three times (0th, 15th, and 30th minute).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of Incubator Cover on Newborn Vital Signs: The Design of Repeated Measurements in Two Separate Groups with No Control Group.
Çetin K, Ekici B. · · 2023 · PMID 37508721 · DOI 10.3390/children10071224

Verify or expand the search:

Other recruiting trials for Neonatal Disease

Currently open trials in the same condition.

NCT06545565 — Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride With Sodium Acetate in Parenteral Nutr · Phase 3 · recruiting
NCT06458699 — Management Of Stoma In Patients Younger Than 3 Months Old · active not recruiting
NCT06408480 — Neonatologist-performed Lung Ultrasound in the Delivery Room · recruiting
NCT06258187 — Pedi-Cap CO2 Detector for Face-mask Ventilation in the Delivery Room · NA · active not recruiting
NCT06594458 — New Procedure to Reduce Mother-newborn Separation · NA · recruiting

Other Maltepe University trials

Trials by the same sponsor.

NCT06209060 — Hammock Position and Nesting in the Neonatal Intensive Care Unit · NA · recruiting
NCT06988748 — Diet Education and Postoperative Outcomes in Pediatric Adenotonsillectomy · NA · not yet recruiting
NCT07272369 — Video vs. Game-Based Teaching of Intramuscular Injection · NA · completed
NCT06626815 — The Effect of Different Kangaroo Positions on Newborns During Heel Lancing · NA · not yet recruiting
NCT06999759 — Concealment of Chemotherapy Drug Serum With a Picture Box Effect on Anxiety, Nausea and Vomiting in Children · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05892809 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maltepe University
Last refreshed: 7 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05892809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing